Aqueous solution comprising 3 - quinuclidinones for the treatment hyperproliferative, autoimmune and heart disease

Details for Australian Patent Application No. 2011208681 (hide)

Owner Aprea AB

Inventors Bystrom, Styrbjorn; Liljebris, Charlotta; Caram-Lelham, Ninus

Agent Davies Collison Cave

Pub. Number AU-A-2011208681

PCT Pub. Number WO2011/089234

Priority 10151326.5 21.01.10 EP; 61/296,964 21.01.10 US

Filing date 21 January 2011

Wipo publication date 28 July 2011

International Classifications

A61K 9/08 Medicinal preparations characterised by special physical form - Solutions

A61K 31/439 - the ring forming part of a bridged ring system, e.g. quinuclidine

A61K 31/444

A61K 31/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/519 - ortho- or peri-condensed with heterocyclic rings

A61K 31/522

A61K 31/5377

A61P 9/00 Drugs for disorders of the cardiovascular system

A61P 35/00 Antineoplastic agents

Event Publications

5 July 2012 PCT application entered the National Phase

  PCT publication WO2011/089234 Priority application(s): WO2011/089234

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011208707-Oil gel

2011208671-Unit for producing ready-to-use fillers by mixing a binder component and a curing agent component